{"id":"https://openalex.org/W74733329","doi":null,"title":"Formulation et caracterisation de nanoparticules combinees de poly(cyanoacrylate d'isobutyle) et de cyclodextrines destinees a l'administration de principes actifs faiblement solubles dans l'eau (doctorat : pharmacotechnie et biopharmacie)","display_name":"Formulation et caracterisation de nanoparticules combinees de poly(cyanoacrylate d'isobutyle) et de cyclodextrines destinees a l'administration de principes actifs faiblement solubles dans l'eau (doctorat : pharmacotechnie et biopharmacie)","publication_year":1998,"publication_date":"1998-01-01","ids":{"openalex":"https://openalex.org/W74733329","mag":"74733329"},"language":"fr","primary_location":{"id":"mag:74733329","doi":null,"is_oa":false,"landing_page_url":"https://www.theses.fr/1998PA114858","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null},"volume":null,"type":"dissertation","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5089742737","display_name":"Airton Monza da Silveira","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Airton Monza da Silveira","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5089742737"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":5,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10256","display_name":"Drug Solubulity and Delivery Systems","score":0.923799991607666,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10256","display_name":"Drug Solubulity and Delivery Systems","score":0.923799991607666,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","score":0.04190000146627426,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.020600000396370888,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cyclodextrins","display_name":"cyclodextrins","score":0.8700000047683716},{"id":"https://openalex.org/keywords/drug-delivery","display_name":"drug delivery","score":0.6119999885559082},{"id":"https://openalex.org/keywords/nanoparticle-formulation","display_name":"nanoparticle formulation","score":0.8550000190734863},{"id":"https://openalex.org/keywords/nanoparticle-characterization","display_name":"nanoparticle characterization","score":0.6679999828338623},{"id":"https://openalex.org/keywords/drug-solubilization","display_name":"drug solubilization","score":0.593999981880188}],"concepts":[{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.45414069294929504},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.4300863444805145}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:74733329","doi":null,"is_oa":false,"landing_page_url":"https://www.theses.fr/1998PA114858","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.4000000059604645}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W249848887","https://openalex.org/W2011984769","https://openalex.org/W35662746","https://openalex.org/W608285550","https://openalex.org/W232533723","https://openalex.org/W4301031808","https://openalex.org/W7046448122","https://openalex.org/W2003045215","https://openalex.org/W7098085406","https://openalex.org/W1966052267"],"abstract_inverted_index":null,"counts_by_year":[],"updated_date":"2025-11-06T04:12:42.849631","created_date":"2016-06-24T00:00:00"}